Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Medicaid generally covers Ozempic for its FDA-approved indication of type 2 diabetes, but does not cover Ozempic for weight loss in patients without diabetes
Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight
OASIS 4 In November 2025, Novo Nordisk reported similar results from its OASIS 4 trial
These alternatives have not undergone the rigorous research required for FDA approval and may not be overseen in the same way the FDA oversees manufacturing and distribution of medication
Helps offset fatigue during titration
US$ 29.44
US$ 21.42
US$ 28.40
